image credit: Unsplash

Pharma CEOs may be subpoenaed as IRA dispute rumbles on

January 22, 2024


The independent Vermont lawmaker is calling on J&J’s Joaquin Duato and Merck’s Robert Davis to explain personally why their medicines generally cost much more in the US. The two CEOs refused to testify in front of the HELP committee last year.

“It is absolutely unacceptable that the CEOs of Johnson & Johnson and Merck have refused an invitation by a majority of members on the HELP Committee to appear before Congress about the outrageously high price of prescription drugs,” said Sanders.

Read More on Pharmaphorum